Chronic myelogenous leukemia (CML) is a malignancy of the myeloid cell lineage genetically characterized by the Philadelphia (Ph) chromosome [t(9;22)(q34;q11)], which generates the BCR-ABL1 fusion gene [7]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.